Get the Stockscreener App
35.89
0.99%
-0.36
After Hours:
35.88
-0.010
-0.03%
Pacs Group Inc stock is traded at $35.89, with a volume of 542.04K.
It is down -0.99% in the last 24 hours and down -4.24% over the past month.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
See More
Previous Close:
$36.25
Open:
$36.49
24h Volume:
542.04K
Relative Volume:
0.65
Market Cap:
$5.68B
Revenue:
$5.43B
Net Income/Loss:
$243.75M
P/E Ratio:
23.84
EPS:
1.5053
Net Cash Flow:
$380.80M
1W Performance:
+1.96%
1M Performance:
-4.24%
6M Performance:
+4.94%
1Y Performance:
+253.94%
1-Day Range:
$35.59
$36.60
1-Week Range:
$34.07
$37.90
52-Week Range:
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
Name
Pacs Group Inc
Sector
Industry
Phone
(801) 447-9829
Address
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
35.89 | 5.74B | 5.43B | 243.75M | 380.80M | 1.5053 |
HCA
Hca Healthcare Inc
|
396.93 | 86.51B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
183.56 | 15.43B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
208.98 | 13.46B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.75 | 12.60B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
99.84 | 9.86B | 6.07B | 793.80M | 464.40M | 5.9914 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-25 | Resumed | JP Morgan | Overweight |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-06-24 | Resumed | JP Morgan | Overweight |
| Oct-09-24 | Initiated | UBS | Buy |
| Sep-11-24 | Resumed | Citigroup | Buy |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| May-06-24 | Initiated | Citigroup | Buy |
| May-06-24 | Initiated | JP Morgan | Overweight |
| May-06-24 | Initiated | Oppenheimer | Outperform |
| May-06-24 | Initiated | RBC Capital Mkts | Outperform |
| May-06-24 | Initiated | Stephens | Overweight |
| May-06-24 | Initiated | Truist | Buy |
View All
Pacs Group Inc Stock (PACS) Latest News
PACS Group (NYSE: PACS) stockholders back all 2026 annual meeting proposals - Stock Titan
Truist reiterates Buy on PACS Group stock citing strong demand By Investing.com - Investing.com South Africa
Director at PACS Group (PACS) receives 4,660 restricted stock units award - Stock Titan
PACS Group (PACS) director awarded 4,660 restricted stock units in Form 4 - Stock Titan
PACS Group (PACS) director awarded 4,660 restricted stock units as equity pay - Stock Titan
PACS Group, Inc. (PACS) director Evelyn Dilsaver awarded 4,660 RSUs - Stock Titan
PACS: Board elections, auditor ratification, and executive pay all approved; no stockholder questions - TradingView
How (PACS) Movements Inform Risk Allocation Models - Stock Traders Daily
PACS GROUP INC (PACS) Stock Chart - ChartMill
PACS Technical Analysis & Stock Price Forecast - Intellectia AI
PACS News | PACS GROUP INC (NYSE:PACS) - ChartMill
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PACS Group - TMX Newsfile
Inside the PACs spending millions on Oklahoma governor's race | Exclusive - The Oklahoman
PACS Group Growth Story Gains Attention Amid Healthcare Expansion - Kalkine Media
PACS Group Q1 earnings call highlights - MSN
PACS Group Price Target Raised to $52.00/Share From $50.00 by Truist Securities - Moomoo
UBS Group AG Sells 175,803 Shares of PACS Group, Inc. $PACS - MarketBeat
PACS Group chief legal officer sells $3.02 million in company stock - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect - ACCESS Newswire
PACS Group chief legal officer sells $3.02 million in company stock By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, I - The National Law Review
[Form 4] PACS Group, Inc. Insider Trading Activity - Stock Titan
PACS Maintains Buy Rating by Truist Securities -- Price Target R - GuruFocus
Earnings call transcript: PACS Group Q1 2026 beats EPS forecast - Investing.com UK
PACS Group Is Maintained at Buy by Truist Securities - Moomoo
Earnings call transcript: PACS Group Q1 2026 beats EPS forecast By Investing.com - Investing.com Australia
How Pacs Group Inc. (PACS) Affects Rotational Strategy Timing - Stock Traders Daily
Truist Raises Price Target on PACS Group to $52 From $50, Keeps Buy Rating - Moomoo
Big U.S. nursing-home group okays $250M buyback after 184% profit jump - Stock Titan
PACS Group's (NYSE:PACS) Earnings May Just Be The Starting Point - 富途牛牛
PACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Truist raises PACS Group stock price target to $52 on guidance - Investing.com Canada
PACS Investors Have Opportunity to Lead PACS Group Inc. Securities Fraud Lawsuit - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Shareholders to Reach Out - ACCESS Newswire
Is PACS Group (NYSE:PACS) Gaining From NYSE Healthcare Growth? - Kalkine Media
PACS Group (PACS) CFO awarded 48,426 RSUs vesting over three years - Stock Titan
[144] PACS Group, Inc. SEC Filing - Stock Titan
PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Sahm
Why PACS Group Stock Is Getting Hammered Today - TipRanks
UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $50 - Moomoo
PACS Group(PACS) Stock Options Chain | Quotes & News - Moomoo
Results: PACS Group, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Moomoo
UBS Lifts PACS Group Price Target to $50 From $44, Maintains Buy Rating - marketscreener.com
PACS Group Q1 Earnings Call Highlights - sharewise.com
Pacs Group Inc Stock (PACS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):